Sg Americas Securities, LLC Syndax Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$18.82 - $23.79 $584,379 - $738,703	31,051 New	31,051 $637,000
Q4 2023 Jan 12, 2024	BUY	$11.39 - $21.67 $220,145 - $418,837	19,328 Added 196.4%	29,169 $630,000
Q3 2023 Oct 13, 2023	BUY	$14.52 - $21.77 $142,891 - $214,238	9,841 New	9,841 $143,000
Q1 2023 Apr 28, 2023	BUY	$20.66 - $28.98 $1.72 Million - $2.41 Million	83,238 Added 1206.52%	90,137 $1.9 Million
Q4 2022 Feb 02, 2023	SELL	$20.64 - $26.24 $329,558 - $418,974	-15,967 Reduced 69.83%	6,899 $176,000
Q3 2022 Oct 31, 2022	SELL	$18.51 - $24.79 $119,222 - $159,672	-6,441 Reduced 21.98%	22,866 $549,000
Q2 2022 Jul 29, 2022	BUY	$13.64 - $19.48 $65,581 - $93,659	4,808 Added 19.63%	29,307 $564,000
Q1 2022 Apr 29, 2022	BUY	$14.84 - $22.15 $281,589 - $420,296	18,975 Added 343.5%	24,499 $426,000
Q4 2021 Feb 07, 2022	SELL	$15.23 - $22.47 $346,116 - $510,653	-22,726 Reduced 80.45%	5,524 $121,000
Q3 2021 Nov 01, 2021	BUY	$13.87 - $19.8 $391,827 - $559,350	28,250 New	28,250 $540,000
Q2 2021 Aug 12, 2021	SELL	$13.42 - $25.18 $105,105 - $197,209	-7,832 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$19.28 - $24.59 $58,283 - $74,335	3,023 Added 62.86%	7,832 $175,000
Q4 2020 Feb 04, 2021	BUY	$15.1 - $26.44 $72,615 - $127,149	4,809 New	4,809 $107,000
Q3 2020 Nov 09, 2020	SELL	$13.39 - $17.48 $198,332 - $258,913	-14,812 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$8.94 - $20.98 $132,419 - $310,755	14,812 New	14,812 $220,000
Q2 2019 Jul 29, 2019	SELL	$4.9 - $9.31 $51,734 - $98,294	-10,558 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$4.26 - $6.86 $44,977 - $72,427	10,558 New	10,558 $55,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

Black Rock Inc. New York, NY

7.91M
Shares

$103 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

5.84M
Shares

$76.4 Million
9.23% of portfolio
Wellington Management Group LLP Boston, MA

4.99M
Shares

$65.2 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$63.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

4.11M
Shares

$53.7 Million
6.25% of portfolio

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account